Table 4.
Data regarding recovery period | Study Group (n=63) n |
% | Control Group (n=60) n |
% | P |
---|---|---|---|---|---|
Complications | |||||
Present | 22 | 34,92 | 18 | 30,00 | 0,560* |
Absent | 41 | 65,08 | 42 | 70,00 | |
Developing Complications*** | |||||
Respiratory distress | 17 | 77,28 | 12 | 66,67 | 0,288* |
Pain | 1 | 4,54 | 2 | 11,11 | |
Hypotension | 1 | 4,54 | 2 | 11,11 | |
Nausea and vomiting | 3 | 13,64 | 2 | 11,11 | |
Time to treatment of complications (minutes) | |||||
Untreated | 0 | 0 | 11 | 61,12 | <0,001* |
0–10 min | 21 | 95,45 | 4 | 22,22 | |
11 min and above | 1 | 4,55 | 3 | 16,66 | |
Treatments administered to the complications | |||||
Interventions for respiration | 14 | 63,63 | 2 | 28,57 | 0,202* |
Drug+fluid therapy | 4 | 18,19 | 3 | 42,86 | |
Drug therapy+positioning | 2 | 9,09 | 2 | 28,57 | |
Examination request**** | 2 | 9,09 | 0 | 0 | |
Recovery duration (minute) | 52,46±17,95*****
Range: 25–95 |
45,33±17,12*****
Range: 30–110 |
0,026** |
Chi-square- test,
Independent samples t test
The percentage was calculated on the basis of the number of patients developing complications.
Chest x-ray, arterial blood gas
Mean, standard deviation